fbpx
Knowledge is the first and last step to investing

Biocon transfers India’s branded formulations business to Eris Lifesciences for ₹1,242 crore on a slump sale basis.

Recommended For You

Next Post
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?